跳至主要内容
临床试验/NCT01245322
NCT01245322已完成4 期

Extended Antimicrobial Treatment of Bacterial Vaginosis Combined With Human Lactobacilli to Find the Best Treatment and Minimize the Risk of Relapses

Skaraborg Hospital1 个研究点 分布在 1 个国家目标入组 75 人开始时间: 2007年1月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
75
试验地点
1
主要终点
characterize lactobacilli of human vaginal origin

研究概览

简要总结

The primary objectives of this study were to characterize lactobacilli of human vaginal origin and to investigate if more extended antibiotic treatment against Bacterial Vaginosis, together with adjuvant lactobacilli treatment, could increase the cure rate and furthermore, to investigate factors that could influence relapse.

详细描述

Nine of the vaginal Lactobacillus strains isolated from healthy Swedish women and characterized in the present study were selected for the clinical trial.All women with symptomatic BV fulfilling the inclusion criteria were consecutively offered to participate in a prospective study of adjuvant lactobacilli given in addition to antibiotics. Women included were regularly menstruating women, 18 years or older, with normal gynaecological status, not pregnant or breast-feeding and without signs of other genital tract infections. Exclusion criteria were patients with hormonal intrauterine device without regular menstruation; women infected with Chlamydia trachomatis or with Trichomonas vaginalis, or with a clinical candida infection.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 50 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • were regularly menstruating women, 18 years or older, with normal gynaecological status, not pregnant or breast-feeding and without signs of other genital tract infections.

排除标准

  • Exclusion criteria were patients with hormonal IUD without regular menstruation; women infected with Chlamydia trachomatis or with Trichomonas vaginalis, or with a clinical candida infection

研究组 & 干预措施

Lactobacilli

Active Comparator

different lactobacilli.

干预措施: lactobacilli (Drug)

结局指标

主要结局

characterize lactobacilli of human vaginal origin

时间窗: 24 month

characterize lactobacilli of human vaginal origin

次要结局

  • cure rate after 24 month(24 month)

研究者

发起方
Skaraborg Hospital
申办方类型
Other Gov
责任方
Principal Investigator
主要研究者

Per-Goran Larsson

professor

Skaraborg Hospital

研究点 (1)

Loading locations...

相似试验

Treatment of Bacterial Vaginosis Combined With Human... | 临床试验